Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic

KM Mattocks, DT Moore, DL Wischik, CM Lazar… - Journal of Substance …, 2022 - Elsevier
Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Perspectives of patients receiving telemedicine services for opioid use disorder treatment: A qualitative analysis of user experiences

JL Sousa, P Raja, HA Huskamp… - Journal of addiction …, 2022 - journals.lww.com
Objective Telemedicine for opioid use disorder (tele-OUD) has the potential to increase
access to medications for OUD (MOUD). Fully virtual tele-OUD services, in which all care is …

Telehealth sustains patient engagement in OUD treatment during COVID-19

JR Langabeer II, A Yatsco… - Journal of Substance …, 2021 - Elsevier
The coronavirus disease pandemic of 2019 (COVID-19) has created significant economic
and societal burden, with mortality currently exceeding 615,000 and millions of others …

Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program

R Harris, A Rosecrans, M Zoltick, C Willman… - Drug and alcohol …, 2022 - Elsevier
Background Changes in federal policy during the COVID-19 pandemic allowing for the use
of telemedicine to treat opioid use disorder (OUD) have facilitated innovative strategies to …

Treating patients with opioid use disorder in their homes: an emerging treatment model

L Uscher-Pines, HA Huskamp, A Mehrotra - Jama, 2020 - jamanetwork.com
Approximately 50 000 deaths from opioid overdose occur each year in the US, 1 and the
prevalence of heroin use is increasing. 2 Although more than 2 million people with an opioid …

A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19

R Lockard, KC Priest, J Gregg… - Substance …, 2022 - journals.sagepub.com
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

'Red flags' and 'red tape': telehealth and pharmacy-level barriers to buprenorphine in the United States

L Textor, D Ventricelli, SV Aronowitz - International Journal of Drug Policy, 2022 - Elsevier
Background Structural vulnerabilities for people who use drugs (PWUD) were exacerbated
by the COVID-19 pandemic. In this context, federal lawmakers in the United States (US) …

The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19

JMW Hughto, L Peterson, NS Perry, A Donoyan… - Journal of Substance …, 2021 - Elsevier
Historically, federal and state policies have narrowly defined treatment models that have
resulted in limited access to and engagement in counseling for individuals receiving …

Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic

R Hailu, A Mehrotra, HA Huskamp, AB Busch… - JAMA network …, 2023 - jamanetwork.com
Importance Little is known about the potential implications of the rapid transition to telehealth
during the COVID-19 pandemic for treatment of opioid use disorder (OUD). Objective To …